-
Quince Therapeutics' (QNCX) "Buy" Rating Reiterated at D. Boral Capital
Source: Buzz FX / 02 Jan 2025 11:01:15 America/New_York
Quince Therapeutics' (QNCX) "Buy" Rating Reiterated at D. Boral Capital Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Quince Therapeutics ( NASDAQ:QNCX - Get Free Report ) 's stock had its "buy" rating reiterated by
Read more...